Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-07T05:17:46.186Z Has data issue: false hasContentIssue false

Economic impact of clinical mastitis in a dairy herd assessed by stochastic simulation using different methods to model yield losses

Published online by Cambridge University Press:  23 October 2008

C. Hagnestam-Nielsen*
Affiliation:
Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, P.O. Box 7023, SE-750 07 Uppsala, Sweden
S. Østergaard
Affiliation:
Faculty of Agricultural Sciences, University of Aarhus, Research Centre Foulum, P.O. Box 50, DK-8830 Tjele, Denmark

Abstract

The main aim of the present study was to examine the economic consequences of a reduction in the incidence of clinical mastitis (CM) at herd level under current Swedish farming conditions. A second objective was to ask whether the estimated cost of CM alters depending upon whether the model reflects the fact that in different stages of lactation, CM gives rise to different yield-loss patterns or postulates just one type of yield-loss pattern irrespective of when, during lactation, CM occurs. A dynamic and stochastic simulation model, SimHerd, was used to study the effects of CM in a herd with 150 cows (9000 kg of energy-corrected milk per cow-year). Four herd types, defined by production level and reproductive performance, were modelled to investigate possible interactions between herd type and response to a reduction in the risk of CM. Technical and economic results, given the initial incidence of CM (25.6 per 100 cow-years), were studied together with the consequences of reducing the initial risk of CM by 50% and 90% throughout lactation and the consequences of reducing the initial risk by 50% and 90% before peak yield. A conventional way of modelling yield losses – i.e. one employing a single yield-loss pattern irrespective of when, during the lactation period, the cow develops CM – was compared with a new modelling strategy in which CM was assumed to affect production differently depending on its lactational timing. The effect of the choice of reference level when estimating yield losses was investigated by comparing the results obtained using the potential yield of mastitic cows, had they not developed CM, with those obtained using the yield of non-mastitic cows. The yearly maximum avoidable cost of CM at herd level was estimated at €14 504, corresponding to 6.9% of the net return given the initial incidence of CM. Expressed per cow-year, the maximum avoidable cost was €97. The cost per case of CM was estimated at €428. Herd types all responded in a similar manner to the reduced relative risk of CM. There were no major differences in the results obtained using the new and the conventional modelling strategy, with the exception of the cost per case of CM. Similarities between the results obtained using the two methods were particularly evident when the mastitic cows’ own yield level, had they not developed CM, was used as the reference for production in healthy cows when yield losses were estimated. It was concluded that the conventional way of modelling yield losses is adequate and should, for the foreseeable future, be used in decision support systems.

Information

Type
Full Paper
Copyright
Copyright © The Animal Consortium 2008
Figure 0

Table 1 Definition of the mastitis periods used in the simulation and the empirical numbers of clinical mastitis cases occurring within each period in the study by Hagnestam et al. (2007)

Figure 1

Figure 1 Yield loss (kg of energy-corrected milk/day) in different weeks of lactation, expressed relative to the cow’s own yield potential, in cows diagnosed with clinical mastitis in lactation week 1 (×), lactation week 2 (▴), lactation week 3 (▵), lactation week 6 (▪) and lactation week 15 (□). The solid line represents conventional modelling. Diagnosis occurred at the time of peak yield loss.

Figure 2

Table 2 Parameterization of the three-line spline functions describing the yield-loss patterns caused by clinical mastitis in primiparous cows with own potential yield of mastitic primiparous cows as reference level for the yield loss

Figure 3

Table 3 Parameterization of the three-line spline functions describing the yield-loss patterns caused by clinical mastitis in multiparous cows with own potential yield of mastitic multiparous cows as reference level for the yield loss

Figure 4

Figure 2 The somatic cell count profile (mean values) in non-mastitic primiparous cows (▵) and non-mastitic multiparous cows (○). Primiparous cows diagnosed with clinical mastitis in the 4th week of lactation (▴) and multiparous cows diagnosed with clinical mastitis in the 15th week of lactation (●) are also shown.

Figure 5

Figure 3 The relative risk of clinical mastitis (CM) during different weeks of lactation. White bars represent primiparous cows and grey bars represent multiparous cows. The lines depict the functions used when applying the conventional strategy. The dotted line represents primiparous cows and the solid line represents multiparous cows.

Figure 6

Table 4 Applied prices and costs

Figure 7

Table 5 Incidence of clinical mastitis per 100 cow-years in the mastitis periods given different relative risks of clinical mastitis. Different superscripts within rows indicate significantly different incidences (P < 0.05).

Figure 8

Table 6 Technical results given the initial relative risk of clinical mastitis and when that risk was reduced. Different superscripts within rows indicate significant differences between the results achieved given different risks of clinical mastitis (P < 0.05).

Figure 9

Table 7 Annual economic results (€) given the initial relative risk of clinical mastitis and when that risk was reduced. Different superscripts within rows indicate significant differences between the results achieved given different risks of clinical mastitis (P < 0.05).

Figure 10

Table 8 Annual technical and economic results achieved in different types of herd given the initial relative risk of clinical mastitis and when that risk was reduced by 90%. Different superscripts within rows indicate significant differences between the effects of a reduction of the initial relative risk by 90% in different types of herd (P < 0.05).

Figure 11

Table 9 Effects of the method used for modelling yield losses, and of the chosen reference level when yield losses were estimated, on technical results. Different superscripts within rows indicate significant differences between the different methods as regards the effects of reducing the initial relative risk of clinical mastitis (P < 0.05).

Figure 12

Table 10 Effects of the method used for modelling yield losses, and of the chosen reference level when yield losses were estimated, on annual economic results (€). Different superscripts within rows indicate significant differences between the different methods as regards the effects of reducing the initial relative risk of clinical mastitis (P < 0.05).

Figure 13

Table 11 Cost per case of clinical mastitis (€) in different types of herd